6152 Journal of Medicinal Chemistry, 2010, Vol. 53, No. 16
Coteroꢀn et al.
(5) Rosenthal, P. J.; McKerrow, J. H.; Aikawa, M.; Nagasawa, H.;
Leech, J. H. A malarial cysteine proteinase is necessary for hemo-
globin degradation by Plasmodium falciparum. J. Clin. Invest. 1988,
82, 1560–1566.
(6) Gamboa de Dominguez, N. D.; Rosenthal, P. J. Cysteine protei-
nase inhibitors block early steps in hemoglobin degradation by
cultured malaria parasites. Blood 1996, 87, 4448–4454.
(7) Rosenthal, P. J.; Nelson, R. G. Isolation and characterization of a
cysteine proteinase gene of Plasmodium falciparum. Mol. Biochem.
Parasitol. 1992, 51, 143–152.
(8) Salas, F.; Fichmann, J.; Lee, G. K.; Scott, M. D.; Rosenthal, P. J.
Functional expression of falcipain, a Plasmodium falciparum cy-
steine proteinase, supports its role as a malarial hemoglobinase.
Infect. Immun. 1995, 63, 2120–2125.
(9) Rosenthal, P. J.; Sijwali, P. S.; Singh, A.; Shenai, B. R. Cysteine
proteases of malaria parasites: targets for chemotherapy. Curr.
Pharm. Des. 2002, 8, 1659–1672.
(10) Shenai, B. R.; Sijwali, P. S.; Singh, A.; Rosenthal, P. J. Character-
ization of native and recombinant falcipain-2, a principal tropho-
zoite cysteine protease and essential hemoglobinase of Plasmodium
falciparum. J. Biol. Chem. 2000, 275, 29000–29010.
(11) Sijwali, P. S.; Shenai, B. R.; Gut, J; Singh, A.; Rosenthal, P. J.
Expression and characterization of the Plasmodium falciparum
haemoglobinase falcipain-3. Biochem. J. 2001, 360, 481–489.
(12) Shenai, B. R.; Rosenthal, P. J. Reducing requirements for hemo-
globin hydrolysis by Plasmodium falciparum cysteine proteases.
Mol. Biochem. Parasitol. 2002, 122, 99–104.
(13) Sijwali, P. S.; Koo, J.; Singh, N.; Rosenthal, P. J. Gene disruptions
demonstrate independent roles for the four falcipain cysteine
proteases of Plasmodium falciparum. Mol. Biochem. Parasitol.
2006, 150, 96–106.
Young, R. N.; Wesolowski, G.; Rodan, S. B.; Johnson, C.;
Kimmel, D. B.; Rodan, G. Design and synthesis of tri-ring P3
benzamide-containing amino-nitriles as potent, selective, orally
effective inhibitors of cathepsin K. J. Med. Chem. 2005, 48,
7520–7534.
(22) Altmann, E.; Aichholz, R.; Betschart, C.; Buhl, T.; Green, J.;
Lattmann, R.; Missbach, M. Dipeptide nitrile inhibitors of cathe-
psin K. Bioorg. Med. Chem. Lett. 2006, 16, 2549–2554.
€
€
(23) Loser, R.; Schilling, K.; Dimmig, E.; Gutschow, M. Interaction of
papain-like cysteine proteases with di-peptide derived nitriles.
J. Med. Chem. 2005, 48, 7688–7707.
(24) Teno, N.; Irie, O.; Miyake, T.; Gohda, K.; Horiuchi, M.; Tada, S.;
Nonomura, K.; Kometani, M.; Iwasaki, G.; Betschart, C. New
chemotypes for cathepsin K inhibitors. Bioorg. Med. Chem. Lett.
2008, 18, 2599–2603.
(25) Schechter, I.; Berger, A. On the size of the active site in proteases. I.
Papain. Biochem. Biophys. Res. Commun. 1967, 27 (2), 157–162.
(26) Arvela, R. K.; Leadbeater, N. E. Rapid, easy cyanation of aryl
bromides and chlorides using nickel salts in conjunction with
microwave promotion. J. Org. Chem. 2003, 68, 9122–9125.
(27) Zanon, J.; Klapars, A.; Buchwald, S. L. Copper-catalyzed domino
halide exchange-cyanation of aryl bromides. J. Am. Chem. Soc.
2003, 125, 2890–2891.
(28) Jin, F; Confalone, P. N. Palladium-catalyzed cyanation reactions
of aryl chlorides. Tetrahedron Lett. 2000, 41, 3271–3273.
(29) Bagley, J. R.; Wynn, R. L.; Rudo, F. G.; Doorley, B. M.; Spencer,
H. K.; Spaulding, T. New 4-(heteroanilido)piperidines, structu-
rally related to the pure opioid agonist fentanyl, with agonist and/or
antagonist properties. J. Med. Chem. 1989, 32, 663–671.
(30) Chesterfield, J. H.; McOmie, J. F. W.; Tute, M. S. Pyrimidines. Part
XI. Synthesis of 5-hydroxypyrimidine and related compounds.
J. Chem. Soc. 1960, 4590–4596.
(14) Singh, N; Sijwali, P. S.; Pandey, K. C.; Rosenthal, P. J. Plasmodium
falciparum: biochemical characterization of the cysteine protease
falcipain-20. Exp. Parasitol. 2006, 112, 187–192.
(31) Altman, E.; Hayakawa, K.; Iwasaki, G. Patent Application WO
03020278, 2003.
(15) Sijwali, P. S.; Kato, K.; Seydel, K. B.; Gut, J.; Lehman, J.; Klemba,
M.; Goldberg, D. E.; Miller, L. H.; Rosenthal, P. J. Plasmodium
falciparum cysteine protease falcipain-1 is not essential in erythro-
cytic stage malaria parasites. Proc. Natl. Acad. Sci. U.S.A. 2004,
101, 8721–8726.
(16) Mallari, J. P.; Shelat, A. A.; Obrien, T.; Caffrey, C. R.; Kosinski,
A.; Connelly, M.; Harbut, M.; Greenbaum, D.; McKerrow, J. H.;
Guy, R. K. Development of potent purine-derived nitrile inhibitors
of the trypanosomal protease TbcatB. J. Med. Chem. 2008, 51,
545–552.
(32) Wang, S. X.; Pandey, K. C.; Somoza, J. R.; Sijwali, P. S.; Kor-
temme, T.; Brinen, L.; Fletterick, R. J.; Rosenthal, P. J.; McKer-
row, J. H. Structural basis for unique mechanisms of folding and
hemoglobin binding by a malarial protease. Proc. Natl. Acad. Sci.
U.S.A. 2006, 103, 11503–11508.
(33) Wang, S. X.; Pandey, K. C.; Scharfstein, J.; Whisstock, J.; Huang,
R. K.; Jacobelli, J.; Fletterick, R. J.; Rosenthal, P. J.; Abrahamson,
M.; Brinen, L. S.; McKerrow, J. H. The structure of chagasin in
complex with a cysteine protease clarifies the binding mode and
evolution of an inhibitor family. Structure 2007, 15, 535–543.
(34) Kerr, I. D.; Lee, J. H.; Pandey, K. C.; Harrison, A.; Sajid, M.;
Rosenthal, P. J.; Brinen, L. S. Structures of falcipain-2 and
falcipain-3 bound to small molecule inhibitors: implications for
substrate specificity. J. Med. Chem. 2009, 52, 852–857.
(35) Oballa, R. M.; Truchon, J.-F.; Bayly, C. I.; Chauret, N.; Day, S.;
Crane, S.; Berthelette, C. A generally applicable method for
assessing the electrophilicity and reactivity of diverse nitrile-
containing compounds. Bioorg. Med. Chem. Lett. 2007, 17, 998–
1002.
(36) Exner, O. A Critical Compilation of Substituent Constants. In
Correlation Analysis in Chemistry: Recent Advances; Chapman,
N. B., Shorter, J., Eds.; Plenum Press: New York, 1978; pp 439-540.
(37) Boros, E. E.; Deaton, D. N.; Hasell, A. M.; McFadyen, R. B.;
Miller, A. B.; Miller, L. R.; Paulick, M. G.; Shewcuk, L. M.;
Thompson, J. B.; Willard, D. H.; Wright, L. L. Exploration of the
P2-P3 SAR of aldehyde cathepsin K inhibitors. Bioorg. Med. Chem.
Lett. 2004, 14, 3425–3429.
(17) Hanzlik, R. P.; Zygmunt, J.; Moon, J. B. Reversible covalent
binding of peptide nitriles to papain. Biochim. Biophys. Acta,
Gen. Subj. 1990, 1035, 62–70.
(18) Greenspan, P. D.; Clark, K. L.; Tommasi, R. A.; Cowen, S. D.;
McQuire, L. W.; Farley, D. L.; van Duzer, J. H.; Goldberg, R. L.;
Zhou, H.; Du, Z.; Fitt, J. J.; Coppa, D. E.; Fang, Z.; Macchia, W.;
Zhu, L.; Capparelli, M. P.; Goldstein, R.; Wigg, A. M.; Doughty,
J. R.; Bohacek, R. S.; Knap, A. K. Identification of dipeptidyl
nitriles as potent and selective inhibitors of cathepsin B through
structure-based drug design. J. Med. Chem. 2001, 44, 4524–4534.
(19) Greenspan, P. D.; Clark, K. L.; Cowen, S. D.; McQuire, L. W.;
Tommasi, R. A.; Farley, D. L.; Quadros, E.; Coppa, D. E.; Du, Z.;
Fang, Z.; Zhou, H.; Doughty, J.; Toscano, K. T.; Wigg, A. M.;
Zhou, S. N-Aryl-amino-nitriles as bioavailable peptidomimetic
inhibitors of cathepsin B. Bioorg. Med. Chem. Lett. 2003, 13,
4121–4124.
(20) Robichaud, J.; Oballa, R.; Prasit, P.; Falgueyret, J. P.; Percival,
M. D.; Wesolowski, G.; Rodan, S. B.; Kimmel, D.; Johnson, C.;
Bryant, C.; Venkatraman, S.; Setti, E.; Mendonca, R.; Palmer, J. T.
A novel class of non-peptidic biaryl inhibitors of human cathepsin
K. J. Med. Chem. 2003, 46, 3709–3727.
(21) Palmer, J. T.; Bryant, C.; Wang, D. X.; Davis, D. E.; Setti, E. L.;
Rydzewski, R. M.; Venkatraman, S.; Tian, Z. Q.; Burrill, L. C.;
Mendonca, R. V.; Springman, E.; McCarter, J.; Chung, T.;
Cheung, H.; Janc, J. W.; McGrath, M.; Somoza, J. R.; Enriquez,
P.; Yu, Z. W.; Strickley, R. M.; Liu, L.; Venuti, M. C.; Percival,
M. D.; Falgueyret, J. P.; Prasit, P.; Oballa, R.; Riendeau, D.;
(38) Falgueyret, J.-P.; Desmarais, S.; Oballa, R.; Cameron Black, W.;
ꢀ
Cromlish, W.; Khougaz, K.; Lamontagne, S.; Masse, F.; Riendeau,
D.; Toulmond, S.; Percival, M. D. Lysosomotropism of basic
cathepsin K inhibitors contributes to increased cellular potencies
against off-target cathepsins and reduced functional selectivity.
J. Med. Chem. 2005, 48, 7535–7543.
(39) Sijwali, P. S.; Brinen, L. S.; Rosenthal, P. J. Systematic optimiza-
tion of expression and refolding of the Plasmodium falciparum
cysteine protease falcipain-2. Protein Expression Purif. 2001, 22,
128–134.